Table 2.
Category | Variables | Examined | Seropositive | Prevalence (%) | X2 | p-Value |
---|---|---|---|---|---|---|
Age Group | ≤20 | 65 | 4 | 6.2 | 17.246 | 0.001 |
21–30 | 81 | 2 | 2.5 | |||
31–40 | 74 | 4 | 5.4 | |||
≥41 | 77 | 15 | 19.5 |
Category | Variables | Examined | Seropositive | Prevalence (%) | X2 | p-Value |
---|---|---|---|---|---|---|
Age Group | ≤20 | 65 | 4 | 6.2 | 17.246 | 0.001 |
21–30 | 81 | 2 | 2.5 | |||
31–40 | 74 | 4 | 5.4 | |||
≥41 | 77 | 15 | 19.5 |